Work

Re: Addition of Docetaxel, Zoledronic Acid, or Both to First-Line Long-Term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial

Year: 2016

Type: letter

Source: The Journal of Urology

DOI: 10.1016/j.juro.2016.07.067

Author: Samir S. Taneja

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2476901105

Cites:

Cited by: 1

Related to: 10